Form 4: Akero Therapeutics CFO Sells Shares to Cover Tax Obligations

William Richard White, CFO of Akero Therapeutics, sold 676 shares of common stock on March 12, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 12, 2025, William Richard White, the Chief Financial Officer of Akero Therapeutics, Inc., sold 676 shares of the company's common stock.
• The sale was executed at a price of $44.88 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, White directly owns 61,959 shares of Akero Therapeutics common stock.
• The sale was automatic under the issuer's 'sell-to-cover' policy and not at the discretion of the reporting person.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sell-to-cover for tax obligations). It's neutral from an investment perspective as it doesn't indicate a change in the company's fundamentals or the CFO's long-term outlook.

Positives

• The company has a 'sell-to-cover' policy in place to manage tax obligations for vesting restricted stock units, which simplifies the process for employees.

Industry Context

Sales of shares to cover tax obligations are a routine part of executive compensation and are common in the pharmaceutical industry.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a small percentage of the total outstanding shares and is related to tax obligations.

Key Dates